Menus Subscribe Search

Follow us


Playing Chicken With Antibiotic Resistance

• August 13, 2009 • 12:00 PM

The FDA bans injecting chicken eggs with antibiotics as a human health threat but backs down when industry groups — known collectively as ‘Big Chicken’ — squawk.

Murray Opsteen has 18,000 chickens at his feet. He’s standing very still, so as not to crush them with his size-12 boots. Although the chickens densely carpet the floor around him — so densely they have little room to move — they aren’t making much noise. In fact, the primary sound in Opsteen’s vast barn, known in the poultry industry as a raising shed, comes from half a dozen powerful electric fans pushing the shed’s fetid air. Still, the air reeks, because the chickens are being raised atop their own excrement, a practice that hugely reduces cleaning costs. “They’re birds,” says Opsteen, a broad-backed giant who doesn’t mince his words after 18 years in the poultry business. “And this is the way birds live.”

Here’s how the process works: A nearby egg hatchery sends chicks to Opsteen’s raising shed just a few days after birth. They’re given another 40 days to mature and fatten in the raising shed, and then they’re trucked away to a slaughterhouse operated by a grocery chain. After they leave, Opsteen scrapes six weeks’ worth of excrement off the shed’s concrete floor. Then the next huge flock of chicks arrives.

To help the birds cope with infections — the shed is forever teeming with the many types of bacteria and parasites that thrive in chicken excrement — drugs are mixed into the birds’ supplies of food and water. Opsteen’s not sure exactly what type of drugs they get; he relies on his feed supplier to get the mix right. But on one specific drug issue, Osteen is extremely clear: Although eggs are routinely injected with antibiotics at many North American poultry hatcheries, this was not done with the chickens on Opsteen’s farm, located in Ontario, Canada.

Opsteen’s uncertainty about the types of drugs used on his farm seems incongruous with his insistence that drugs were not used at the hatchery. But Opsteen, after all, is no ordinary farmer. He’s the farmer assigned to handle reporters looking for farm tours here in Ontario, heartland of the chicken industry in Canada, where exports to the U.S. are booming. And today, Opsteen’s been designated by professional chicken-industry media handlers to deliver one major message: On his farm at least, the chickens come from drug-free eggs. “I’m absolutely certain these chicks came from eggs that were not injected with antibiotics,” he says. “In fact, I can guarantee it.”

It’s a long way from Murray Opsteen’s raising shed to the gleaming, ultramodern headquarters of the U.S. Food and Drug Administration near Baltimore. But Opsteen’s preoccupation with denying the practice of injecting antibiotics into eggs — a procedure widely used to help prevent disease in densely packed chicken raising sheds — follows directly from a directive issued by the FDA last year.

Citing concerns that injecting eggs with antibiotics “presents a risk to the public health,” the FDA issued a rule in July 2008 that severely limited antibiotic use in hatcheries. The aim, the FDA said in a carefully reasoned statement backed by government studies from the U.S., Canada and Europe, was to restrict use of a class of antibiotics due to fears that misuse on farms reduced the antibiotics’ effectiveness for humans — a concern long voiced by the American Medical Association, the World Health Organization and public health agencies in numerous countries.

Coming from a federal agency with sweeping legal powers and powerful law-enforcement capabilities, the FDA’s rule was tough stuff — or so it seemed at first. But that was before the powerful U.S. chicken lobby — sometimes dubbed “Big Chicken” — stepped in. Within weeks of the FDA’s antibiotic prohibition, a barn burner of a fight, pitting scientists against farmers and physicians against veterinarians, ignited across the continent. Then, three weeks before the ban was to go into effect, FDA policymakers — mindful of an earlier ban on antibiotic use in poultry that was won only after years of litigation — suddenly abandoned their own ruling.

The target of the FDA’s concern was a category of antibiotics known as cephalosporins, which are highly valued because of their ability to knock out a wide range of otherwise hard-to-treat human ailments, including urinary tract infections and pneumonia. Cephalosporins were first marketed decades back, but doctors rely increasingly on newer, more powerful generations of cephalosporin antibiotics as bacterial resistance to other heavily used antibiotics — including penicillin — has grown. Although they were long considered a back-of-the-shelf drug, to be used only in rare situations when other antibiotics failed, third-, fourth- and fifth-generation cephalosporins have now moved to medicine’s very forefront.

It was with antibiotic resistance in mind that the FDA announced a ban on certain uses of cephalosporins — most notably their injection into poultry eggs, a practice the FDA had never studied or approved. Unrestricted cephalosporin use “is likely to lead to the emergence of cephalosporin-resistant strains of food-borne bacterial pathogens,” the FDA explained. “If these drug-resistant bacterial strains infect humans, it is likely that cephalosporins will no longer be effective for treating disease in those people.”

Cephalosporins are popular on poultry, cattle and pork farms, where the FDA has approved their use for numerous veterinary purposes. But farmers have also adopted “extra-label” uses of cephalosporins. In one such use, just before the egg hatches, robots pierce the shells of chicken eggs, injecting doses of a third-generation cephalosporin antibiotic, ceftiofur, to suppress disease.

This practice, known as preventive use, harnesses ceftiofur’s remarkable medicinal power not just to treat infection outbreaks but to suppress them. By preventing outbreaks from occurring in crowded raising sheds that hold as many as 50,000 birds, antibiotic egg injections help chickens to grow faster. The injections also allow farmers to send more birds to slaughter, even while they grow up in their own excrement.

Over the past decade, however, resistance to cephalosporin antibiotics has increased dramatically in North America, Europe and Asia, causing experts, including Robert Moellering of Harvard Medical School, to warn that thanks to misuse of antibiotics by veterinarians and physicians alike “we are perilously close” to not having drugs to treat tough-to-beat infections such as gonorrhea. “There are very few situations where we have no therapeutic options,” Moellering says, noting that eight patients recently died in New York City when cephalosporins and other antibiotics failed, “but we are getting close.”

From the farmer’s perspective, using antibiotics as growth promoters — an approach that U.S. Department of Agriculture antibiotics expert Todd Callaway estimates accounts for half of all drug use on farms — is simply money in the bank. Obviously, widespread agricultural use also greatly benefits ceftiofur’s manufacturer, Pfizer Inc.

And money brings popularity: According to a 2004 study of 24 hatcheries in the Canadian province of Quebec, ceftiofur was injected into eggs in every hatchery studied. In the U.S., according to a summary of a 2001 FDA investigation of 27 chicken and turkey hatcheries obtained by a Chicago-based group, the Food Animal Concerns Trust, four hatcheries reported injecting eggs, while four others reported injecting already-hatched birds. The real extent of ceftiofur usage may have been greater; more than a third of the hatcheries “kept poor or no treatment records,” the FDA reported.

When it comes to tracking drug use on factory farms, says Toni Poole, a USDA specialist on the use of antibiotics, secrecy is a serious problem. Penetrating that secrecy has become an urgent priority for a small but influential group of scientists. Alarmed about the global spread of bacteria resistant to up to as many as 10 types of antibiotics, governments in Europe, Canada and the U.S. established national surveillance systems late in the 1990s in an attempt to track human resistance to antibiotics in relation to usage of antibiotics on farms. What they have found — especially regarding links between ceftiofur use in poultry and human resistance to cephalosporins — has not been welcomed by the meat and poultry industries.

The scientists’ opening salvo came in 2006, when a group of the most senior antibiotic-resistance experts from the FDA, the Public Health Agency of Canada, France’s National Microbiology Laboratory and Belgium’s Veterinary and Agricultural Research Centre warned in a comprehensive review of published data that cephalosporin-resistant bacteria “are frequently recovered from animals and food, with poultry as primary food source, suggesting that humans are often infected by these routes.”

A subsequent series of studies in Europe and North America has convinced researchers — including Frank Aarestrup, a specialist on antibiotic resistance with the Danish Technical University in Copenhagen who helped introduce a system of comprehensive surveillance of veterinary drug use in Denmark — that the link between veterinary antibiotic use and human resistance has been proven. “Taken in context with all the other knowledge we have,” Aarestrup says, “anyone still opposing a link between antibiotic use in food animal production and direct human health impact does so for other reasons than science.”

In a recently published review of international studies on the issue, Aarestrup noted that a Canadian study found the adoption of universal use of ceftiofur in hatcheries in Quebec earlier this decade matched a rapid increase in human resistance to the drug. When this problem was brought to the attention of public health authorities, hatcheries voluntarily stopped using ceftiofur — and there was a rapid decrease in resistance to cephalosporins in humans.

The data cannot conclusively link drug use in poultry with human resistance, says James Johnson, an infectious disease specialist with the Veterans Administration Medical Center in Minneapolis. But like Aarestrup, Johnson thinks the data “is as good as it gets” in terms of signals about the dangers of ceftiofur use in hatcheries. Canadian veterinarians agree: Last year, the Canadian Veterinary Medical Association instructed its members not to use ceftiofur for extra-label purposes such as hatchery injections. The Canadian government also acted, last year ordering Pfizer to include a warning against extra-label use on ceftiofur packages.

Rebecca Irwin, who manages the Canadian farm antibiotic surveillance system, says that strong as the data implicating ceftiofur use in hatcheries with human resistance is, it would be even stronger if the poultry industry weren’t so secretive about drug use. “People can hide behind whatever,” she told a gathering of scientists in early May. “We’re still getting the ‘hear no evil, see no evil, speak no evil’ from numerous sources.”

Although chicken farmers seldom discuss their use of drugs — especially high-profile drugs such as cephalosporin — the veterinarians they employ are obliged to be more open, thanks to professional codes requiring at least a degree of scientific transparency. So when it came to mounting a response to the FDA’s prohibition of extra-label use of cephalosporins on farms, the industry turned to the American Veterinary Medical Association. The AVMA represents 78,000 veterinarians working in private and corporate practice, the government, industry, academia and the military.

In a toughly worded, 18-page letter drafted by a panel of veterinarians employed on chicken farms across the U.S., the AVMA broke ranks with its Canadian counterpart veterinarian organization, arguing that the FDA’s rule against extra-label cephalosporin use was completely unjustified. The Canadian, American and European studies cited by the FDA fail to directly demonstrate that veterinary use of ceftiofur impairs human medicine, the AVMA insists, and the FDA prohibition would put animals at risk. “Because veterinarians have a relatively limited number of FDA-approved drugs for treatment of the numerous animal species,” the American veterinarians’ group said, “extra-label cephalosporin use is medically necessary to relieve animal pain and suffering and allow veterinarians discretion to use drugs judiciously.”

Just weeks after the group filed its protest, the FDA reversed course. Late in November 2008, amid a crescendo of last-minute regulatory interventions by the outgoing Bush administration, William Flynn, acting director of the FDA’s Center for Veterinary Medicine, announced the restrictions on cephalosporin use were being withdrawn to allow the agency to “fully consider” comments, including the AVMA’s. “We responded through the AVMA,” says the National Chicken Council‘s Steve Pretanick. “They worked up the argument as to why the FDA should not take this action. As a result, the FDA withdrew it. And that’s the last I’ve heard of it.”

In Pretanick’s account, the business of getting the FDA to knuckle under sounds like a routine event. But Margaret Mellon, head of the food and environment program for the Washington-based Union of Concerned Scientists, describes a “take no prisoners attitude” on the part of the chicken industry at a time when it knew it could count on the White House.

“The past administration didn’t believe in regulation,” Mellon says. But she also believes the FDA itself “miscalculated the blowback” from the industry and its powerful rural political allies.

The FDA now refuses to discuss the matter. But speaking to scientists in Kansas in May, Flynn suggested the FDA’s retreat may not be permanent. The agency, he said, may try again to reintroduce restrictions sometime soon. Until that happens, however, poultry farmers will remain free to play chicken with some of the most important antibiotics in human medicine.

Sign up for our free e-newsletter.

Are you on Facebook? Become our fan.

Follow us on Twitter.

Add our news to your site.

Paul Webster
Paul Webster, based in Toronto, has directed documentary films and written about science, medicine and the environment in more than 20 countries. His recent work includes a film about religious freedom in China and magazine articles about health care in Iraq and the impacts of pesticides on migratory birds.

More From Paul Webster

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

November 21 • 4:00 PM

Why Are America’s Poorest Toddlers Being Over-Prescribed ADHD Drugs?

Against all medical guidelines, children who are two and three years old are getting diagnosed with ADHD and treated with Adderall and other stimulants. It may be shocking, but it’s perfectly legal.



November 21 • 2:00 PM

The Best Moms Let Mess Happen

That’s the message of a Bounty commercial that reminds this sociologist of Sharon Hays’ work on “the ideology of intensive motherhood.”


November 21 • 12:00 PM

Eating Disorders Are Not Just for Women

Men, like women, are affected by our cultural preoccupation with thinness. And refusing to recognize that only makes things worse.


November 21 • 10:00 AM

Queens of the South

Inside Asheville, North Carolina’s 7th annual Miss Gay Latina pageant.


November 21 • 9:12 AM

‘Shirtstorm’ and Sexism in Science

Following the recent T-shirt controversy, it’s clear that sexism in science persists. But the forces driving the gender gap are still being debated.


November 21 • 8:00 AM

What Makes a Film Successful in 2014?

Domestic box office earnings are no longer a reliable metric.



November 21 • 6:00 AM

What Makes a City Unhappy?

According to the National Bureau of Economic Research, Dana McMahan splits time between two of the country’s unhappiest cities. She set out to explore the causes of the happiness deficits.


November 21 • 5:04 AM

Sufferers of Social Anxiety Disorder, Your Friends Like You

The first study of friends’ perceptions suggest they know something’s off with their pals but like them just the same.


November 21 • 4:00 AM

In 2001 Study, Black Celebrities Judged Harshly in Rape Cases

When accused of rape, black celebrities were viewed more negatively than non-celebrities. The opposite was true of whites.


November 20 • 4:00 PM

Women, Kink, and Sex Addiction: It’s Not Like the Movies

The popular view is that if a woman is into BDSM she’s probably a sex addict, and vice versa. In fact, most kinky women are perfectly happy—and possibly healthier than their vanilla counterparts.


November 20 • 2:00 PM

A Majority of Middle-Class Black Children Will Be Poorer as Adults

The disturbing findings of a new study.


November 20 • 12:00 PM

Standing Up for My Group by Kicking Yours

Members of a minority ethnic group are less likely to express support for gay equality if they believe their own group suffers from discrimination.


November 20 • 10:00 AM

For Juvenile Records, It’s ‘Justice by Geography’

A new study finds an inconsistent patchwork of policies across states for how juvenile records are sealed and expunged.


November 20 • 8:00 AM

Surviving the Secret Childhood Trauma of a Parent’s Drug Addiction

As a young girl, Alana Levinson struggled with the shame of her father’s substance abuse. But when she looked more deeply into the research on children of drug-addicted parents, she realized society’s “conspiracy of silence” was keeping her—and possibly millions of others—from adequately dealing with the experience.



November 20 • 6:00 AM

Extreme Weather, Caused by Climate Change, Is Here. Can Nike Prepare You?

Following the approach we often see from companies marketing products before big storms, Nike focuses on climate change science in the promotion of its latest line of base-layer apparel. Is it a sign that more Americans are taking climate change seriously? Don’t get your hopes up.


November 20 • 5:00 AM

How Old Brains Learn New Tricks

A new study shows that the neural plasticity needed for learning doesn’t vanish as we age—it just moves.


November 20 • 4:00 AM

The FBI’s Dangerous Misrepresentation of Encryption Law

The FBI no more deserves a direct line to your data than it deserves to intercept your mail at the post office. But it doesn’t want you to know that.


November 20 • 2:00 AM

Brain Drain Is Economic Development

It may be hard to see unless you shift your focus from places to people, but both destination and source can benefit from “brain drain.”


November 19 • 9:00 PM

Gays Rights Are Great, but Ixnay on the PDAs

New research suggests both heterosexuals and gay men are uncomfortable with public same-sex kissing.


November 19 • 4:00 PM

The Red Cross’ Own Employees Doubt the Charity’s Ethics

Survey results obtained by ProPublica also show a crisis of trust in the charity’s senior leadership.



November 19 • 2:00 PM

Egg Freezing Isn’t the Feminist Issue You Think It Is

New benefits being offered by Apple and Facebook probably aren’t about discouraging women from becoming mothers at a “natural” age.


Follow us


Sufferers of Social Anxiety Disorder, Your Friends Like You

The first study of friends' perceptions suggest they know something's off with their pals but like them just the same.

Standing Up for My Group by Kicking Yours

Members of a minority ethnic group are less likely to express support for gay equality if they believe their own group suffers from discrimination.

How Old Brains Learn New Tricks

A new study shows that the neural plasticity needed for learning doesn't vanish as we age—it just moves.

Ethnic Diversity Deflates Market Bubbles

But it's not in the rainbow and sing-along way you'd hope for. We just don't trust outsiders' judgments.

Online Brain Exercises Are Probably Useless

Even under the guidance of a specialist trainer, computer-based brain exercises have only modest benefits, a new analysis shows.

The Big One

One company, Comcast, will control up to 40 percent of Internet service coverage in the U.S., and 19 of the top 20 cable markets, if a proposed merger with Time Warner Cable is approved by regulators. November/December 2014

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.